Please assess the completion status of the following clinical trial:

Trial Title: Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: None
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Healthy subjects at least 18 years of age~* Written informed consent obtained prior to study entry~* Subjects correctly included and having completed clinical studies IC51-301 (NCT00604708) and IC51-302 (NCT00605085) with at least one vaccination~Exclusion Criteria:~* Inability or unwillingness to provide informed consent and to abide the requirements of the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).